Leukocyte trafficking mechanisms in epilepsy

Molecular Immunology

Volumn 55, Issue 1, 2013, Pages 100-104

  Fabene, Paolo F ^a   Laudanna, Carlo ^b   Constantin, Gabriela ^b  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

Adhesion molecules; Chemokines; Epilepsy; Inflammation; Leukocyte trafficking; Seizures

Indexed keywords

ANTICONVULSIVE AGENT; CHEMOKINE; CYTOKINE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; NATALIZUMAB; RANTES; TUMOR NECROSIS FACTOR; VASCULAR CELL ADHESION MOLECULE 1;

ANTICONVULSANT THERAPY; BLOOD BRAIN BARRIER; CELL ADHESION; CELL MIGRATION; EPILEPSY; HUMAN; LEUKOCYTE; LEUKOCYTE ADHERENCE; NONHUMAN; PARENCHYMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SEIZURE; UPREGULATION;

ANIMALS; CELL ADHESION; CHEMOKINES; CHEMOTAXIS, LEUKOCYTE; CYTOKINES; EPILEPSY; HUMANS; LEUKOCYTES; MODELS, BIOLOGICAL; MOLECULAR TARGETED THERAPY; SEIZURES;

EID: 84875607835     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2012.12.009     Document Type: Review

References (40)

1. Bell M.D., Perry V.H. Adhesion molecule expression on murine cerebral endothelium following the injection of a proinflammagen or during acute neuronal degeneration. Journal of Neurocytology 1995, 24:695-710.
2. Bernard C., Esclapez M., Hirsch J.C., Ben-Ari Y. Interneurones are not so dormant in temporal lobe epilepsy: a critical reappraisal of the dormant basket cell hypothesis. Epilepsy Research 1998, 32:93-103.
3. Blamire A.M., Anthony D.C., Rajagopalan B., Sibson N.R., Perry V.H., Styles P. Interleukin-1beta-induced changes in blood-brain barrier permeability, apparent diffusion coefficient, and cerebral blood volume in the rat brain: a magnetic resonance study. Journal of Neuroscience 2000, 20:8153-8159.
4. Boer K., Jansen F., Nellist M., Redeker S., van den Ouweland A.M., Spliet W.G., van Nieuwenhuizen O., Troost D., Crino P.B., Aronica E. Inflammatory processes in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex. Epilepsy Research 2008, 78:7-21.
5. Bolton S.J., Anthony D.C., Perry V.H. Loss of the tight junction proteins occludin and zonula occludens-1 from cerebral vascular endothelium during neutrophil-induced blood-brain barrier breakdown in vivo. Neuroscience 1998, 86:1245-1257.
6. Fabene P.F., Bramanti P., Constantin G. The emerging role for chemokines in epilepsy. Journal of Neuroimmunology 2010, 224:22-27.
7. Fabene P.F., Navarro Mora G., Martinello M., Rossi B., Merigo F., Ottoboni L., Bach S., Angiari S., Benati D., Chakir A., Zanetti L., Schio F., Osculati A., Marzola P., Nicolato E., Homeister J.W., Xia L., Lowe J.B., McEver R.P., Osculati F., Sbarbati A., Butcher E.C., Constantin G. A role for leukocyte-endothelial adhesion mechanisms in epilepsy. Nature Medicine 2008, 14:1377-1383.
8. Foresti M.L., Arisi G.M., Katki K., Montañez A., Sanchez R.M., Shapiro L.A. Chemokine CCL2 and its receptor CCR2 are increased in the hippocampus following pilocarpine-induced status epilepticus. Journal of Neuroinflammation 2009, 24:6-40.
9. Gautam N., Herwald H., Hedqvist P., Lindbom L. Signaling via beta(2) integrins triggers neutrophil-dependent alteration in endothelial barrier function. Journal of Experimental Medicine 2000, 191:1829-1839.
10. Greenwood J., Etienne S., Adamson P., Couraud P.O. Lymphocytes migration into the central nervous system: implication of ICAM-1 signalling at the blood-brain barrier. Vascular Pharmacology 2002, 38:315-322.
11. Hellwig K., Gold R. Progressive multifocal leukoencephalopathy and natalizumab. Journal of Neurology 2011, 258:1920-1928.
12. Herman S.T. Epilepsy after brain insult. Targetting epileptogenesis. Neurology 2002, 59(Suppl. 5):S21-S26.
13. Hildebrandt M., Amann K., Schröder R., Pieper T., Kolodziejczyk D., Holthausen H., Buchfelder M., Stefan H., Blümcke I. White matter angiopathy is common in pediatric patients with intractable focal epilepsies. Epilepsia 2008, 49:804-815.
14. Holmes G.L. Effects of seizures on brain development: lessons from the laboratory. Pediatric Neurology 2005, 33:1-11.
15. Ibbotson G.C., Doig C., Kaur J., Gill V., Ostrovsky L., Fairhead T., Kubes P. Functional alpha4-integrin: a newly identified pathway of neutrophil recruitment in critically ill septic patients. Nature Medicine 2001, 7:465-470.
16. Ivens S., Kaufer D., Flores L.P., Bechmann I., Zumsteg D., Tomkins O., Seiffert E., Heinemann U., Friedman A. TGF-beta receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis. Brain 2007, 130:535-547.
17. Johnston B., Kubes P. The alpha4-integrin: an alternative pathway for neutrophil recruitment?. Immunology Today 1999, 20:545-550.
18. Kim J.V., Kang S.S., Dustin M.L., McGavern D.B. Myelomonocytic cell recruitment causes fatal CNS vascular injury during acute viral meningitis. Nature 2009, 457:191-195.
19. Kleen J.K., Holmes G.L. Brain inflammation initiates seizures. Nature Medicine 2008, 14:1377-1383.
20. Ley K., Laudanna C., Cybulsky M.I., Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nature Reviews Immunology 2007, 7:678-689.
21. Librizzi L., Regondi M.C., Pastori C., Frigerio S., Frassoni C., de Curtis M. Expression of adhesion factors induced by epileptiform activity in the endothelium of the isolated guinea pig brain in vitro. Epilepsia 2007, 48:743-751.
22. Lok J., Gupta P., Guo S., Kim W.J., Whalen M.J., van Leyen K., Lo E.H. Cell-cell signaling in the neurovascular unit. Neurochemical Research 2007, 32:2032-2045.
23. Louboutin J.P., Chekmasova A., Marusich E., Agrawal L., Strayer D.S. Role of CCR5 and its ligands in the control of vascular inflammation and leukocyte recruitment required for acute excitotoxic seizure induction and neural damage. FASEB Journal 2011, 25:737-753.
24. Lutterotti A., Martin R. Getting specific: monoclonal antibodies in multiple sclerosis. Lancet Neurology 2008, 7:538-547.
25. Manley N.C., Bertrand A.A., Kinney K.S., Hing T.C., Sapolsky R.M. Characterization of monocyte chemoattractant protein-1 expression following a kainate model of status epilepticus. Brain Research 2007, 1182:138-143.
26. Marchi N., Angelov L., Masaryk T., Fazio V., Granata T., Hernandez N., Hallene K., Diglaw T., Franic L., Najm I., Janigro D. Seizure-promoting effect of blood-brain barrier disruption. Epilepsia 2007, 48:732-742.
27. Mennicken F., Chabot J.G., Quirion R. Systemic administration of kainic acid in adult rat stimulates expression of the chemokine receptor CCR5 in the forebrain. Glia 2002, 37:124-138.
28. Oby E., Janigro D. The blood-brain barrier and epilepsy. Epilepsia 2006, 47:1761-1774.
29. Ravizza T., Noé F., Zardoni D., Vaghi V., Sifringer M., Vezzani A. Interleukin Converting Enzyme inhibition impairs kindling epileptogenesis in rats by blocking astrocytic IL-1beta production. Neurobiology of Disease 2008, 31:327-333.
30. Ravizza T., Gagliardi B., Noé F., Boer K., Aronica E., Vezzani A. Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiology of Disease 2008, 29:142-160.
31. Schiller Y. Seizure relapse and development of drug resistance following long-term seizure remission. Archives of Neurology 2009, 66:1233-1239.
32. Seiffert E., Dreier J.P., Ivens S., Bechmann I., Tomkins O., Heinemann U., Friedman A. Lasting blood-brain barrier disruption induces epileptic focus in the rat somatosensory cortex. The Journal of Neuroscience 2004, 24:7829-7836.
33. Shlosberg D., Benifla M., Kaufer D., Friedman A. Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury. Nature Reviews Neurology 2010, 6:393-403.
34. Sloviter R.S. Permanently altered hippocampal structure, excitability, and inhibition after experimental status epilepticus in the rat: the 'dormant basket cell' hypothesis and its relevance to temporal lobe epilepsy. Hippocampus 1991, 1:41-66.
35. Sotgiu S., Murrighile M.R., Constantin G. Treatment of refractory epilepsy with natalizumab in a patient with multiple sclerosis. Case report. BMC Neurology 2010, 10:84.
36. van Vliet E.A., da Costa Araújo S., Redeker S., van Schaik R., Aronica E., Gorter J.A. Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy. Brain 2007, 130:521-534.
37. Vezzani A., Aronica E., Mazarati A., Pittman Q.J. Epilepsy and brain inflammation. Experimental Neurology 2011, (Epub ahead of print).
38. Vezzani A., Balosso S., Ravizza T. The role of cytokines in the pathophysiology of epilepsy. Brain, Behavior and Immunity 2008, 22:797-803.
39. Wenning W., Haghikia A., Laubenberger J., Clifford D.B., Behrens P.F., Chan A., Gold R. Treatment of progressive multifocal leukoencephalopathy associated with natalizumab. New England Journal of Medicine 2009, 361:1075-1080.
40. Xu J.H., Long L., Tang Y.C., Zhang J.T., Hut H.T., Tang F.R. CCR3, CCR2A and macrophage inflammatory protein (MIP)-1a, monocyte chemotactic protein-1 (MCP-1) in the mouse hippocampus during and after pilocarpine-induced status epilepticus (PISE). Neuropathology and Applied Neurobiology 2009, 35:496-514.